Optimisation of floating matrix tablets and evaluation of their gastric residence time S Baumgartner, J Kristl, F Vrečer, P Vodopivec, B Zorko International journal of pharmaceutics 195 (1-2), 125-135, 2000 | 633 | 2000 |
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody P Kocbek, N Obermajer, M Cegnar, J Kos, J Kristl Journal of controlled release 120 (1-2), 18-26, 2007 | 574 | 2007 |
Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs P Kocbek, S Baumgartner, J Kristl International journal of pharmaceutics 312 (1-2), 179-186, 2006 | 544 | 2006 |
The impact of relative humidity during electrospinning on the morphology and mechanical properties of nanofibers J Pelipenko, J Kristl, B Janković, S Baumgartner, P Kocbek International journal of pharmaceutics 456 (1), 125-134, 2013 | 416 | 2013 |
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol K Teskač, J Kristl International Journal of Pharmaceutics 390 (1), 61-69, 2010 | 355 | 2010 |
Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature Š Zupančič, Z Lavrič, J Kristl European Journal of Pharmaceutics and Biopharmaceutics 93, 196-204, 2015 | 349 | 2015 |
Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells C Caddeo, K Teskač, C Sinico, J Kristl International Journal of Pharmaceutics 363 (1-2), 183-191, 2008 | 288 | 2008 |
Critical attributes of nanofibers: Preparation, drug loading, and tissue regeneration J Pelipenko, P Kocbek, J Kristl International journal of pharmaceutics 484 (1-2), 57-74, 2015 | 278 | 2015 |
Thermoresponsive polymers: Insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications MR Matanović, J Kristl, PA Grabnar International journal of pharmaceutics 472 (1-2), 262-275, 2014 | 276 | 2014 |
Advantages of celecoxib nanosuspension formulation and transformation into tablets A Dolenc, J Kristl, S Baumgartner, O Planinšek International journal of pharmaceutics 376 (1-2), 204-212, 2009 | 245 | 2009 |
Toxicological Aspects of Long‐Term Treatment of Keratinocytes with ZnO and TiO2 Nanoparticles P Kocbek, K Teskač, ME Kreft, J Kristl Small 6 (17), 1908-1917, 2010 | 244 | 2010 |
Comparative rheological investigation of crude gastric mucin and natural gastric mucus J Kočevar-Nared, J Kristl, J Šmid-Korbar Biomaterials 18 (9), 677-681, 1997 | 221 | 1997 |
The role of rheology of polymer solutions in predicting nanofiber formation by electrospinning R Rošic, J Pelipenko, P Kocbek, S Baumgartner, M Bešter-Rogač, J Kristl European Polymer Journal 48 (8), 1374-1384, 2012 | 219 | 2012 |
Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs T Potrč, S Baumgartner, R Roškar, O Planinšek, Z Lavrič, J Kristl, ... European Journal of Pharmaceutical Sciences 75, 101-113, 2015 | 205 | 2015 |
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration P Ahlin, J Kristl, A Kristl, F Vrečer International Journal of Pharmaceutics 239 (1-2), 113-120, 2002 | 205 | 2002 |
Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions P Ahlin, J Kristl, J Šmid-Korbar Acta Pharmaceutica (Zagreb) 48 (4), 259-267, 1998 | 184 | 1998 |
Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method M Šentjurc, K Vrhovnik, J Kristl Journal of controlled release 59 (1), 87-97, 1999 | 177 | 1999 |
Hydrocolloids and gels of chitosan as drug carriers J Kristl, J Šmid-Korbar, E Štruc, M Schara, H Rupprecht International Journal of Pharmaceutics 99 (1), 13-19, 1993 | 162 | 1993 |
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers P Ahlin Grabnar, J Kristl Journal of microencapsulation 28 (4), 323-335, 2011 | 151 | 2011 |
An investigation into keratinolytic enzymes to enhance ungual drug delivery M Mohorčič, A Torkar, J Friedrich, J Kristl, S Murdan International journal of pharmaceutics 332 (1-2), 196-201, 2007 | 138 | 2007 |